crossbody
Diamond Member
- Jan 30, 2024
- 1,910
- 1,757
- 1,893
Several recent studies have added to the growing body of scientific evidence linking COVID-19 vaccines to cancer. The first study is a new preprint that shows the spike protein in the SARS-CoV-2 virus and mRNA vaccines inhibits a crucial protein that suppresses tumors, potentially causing a greater incidence of cancer.
First Study of Scientific Evidence
The study, entitled “SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells,” was authored by researchers from Brown University, who wanted to investigate whether the S2 component of the spike protein in the vaccine and the virus interacted with a tumor suppressor protein known as P53 that plays a vital role in DNA damage response and repair. They found that the S2 component suppresses the P53, a finding that “provides a potential molecular mechanism by which SARS-CoV-2 infection may impact tumorigenesis, tumor progression and chemotherapy sensitivity.”
Meaning: This means that a component in the spike protein of the virus can cause tumors to develop and might inhibit any positive effects brought about by cancer therapies. Although their study focused on the spike protein in the virus itself, the researchers said that the results also have implications for the mRNA jabs because they instruct the body to create the same spike protein found in the virus.
Results: They wrote: “Our results have implications for the biological effects of spike S2 subunit in human cells whether spike is present due to primary COVID-19 infection or due to mRNA vaccines where its expression is used to promote anti-viral immunity.”
Findings: This study serves to confirm previous findings, such as an October 2020 study published in Translational Oncology that noted the interaction between S2 proteins and the P53 tumor suppressor protein, along with an October 2021 peer-reviewed study in the Journal of Viruses that reached a similar finding.
kirschsubstack.com
First Study of Scientific Evidence
The study, entitled “SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells,” was authored by researchers from Brown University, who wanted to investigate whether the S2 component of the spike protein in the vaccine and the virus interacted with a tumor suppressor protein known as P53 that plays a vital role in DNA damage response and repair. They found that the S2 component suppresses the P53, a finding that “provides a potential molecular mechanism by which SARS-CoV-2 infection may impact tumorigenesis, tumor progression and chemotherapy sensitivity.”
Meaning: This means that a component in the spike protein of the virus can cause tumors to develop and might inhibit any positive effects brought about by cancer therapies. Although their study focused on the spike protein in the virus itself, the researchers said that the results also have implications for the mRNA jabs because they instruct the body to create the same spike protein found in the virus.
Results: They wrote: “Our results have implications for the biological effects of spike S2 subunit in human cells whether spike is present due to primary COVID-19 infection or due to mRNA vaccines where its expression is used to promote anti-viral immunity.”
Findings: This study serves to confirm previous findings, such as an October 2020 study published in Translational Oncology that noted the interaction between S2 proteins and the P53 tumor suppressor protein, along with an October 2021 peer-reviewed study in the Journal of Viruses that reached a similar finding.
Two new studies suggest mRNA Covid vaccines can contribute to cancer formation
A new preprint provides evidence that the spike protein of both SARS-CoV-2 and mRNA vaccinations inhibits an important tumor suppressor protein, which may lead to increased incidence of cancer. The preprint, titled ‘SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death...
kirschsubstack.com
